Skip to main content Accessibility help
×
Home
  • Print publication year: 2010
  • Online publication date: August 2011

12 - Long-term significance following hypertension in pregnancy

Related content

Powered by UNSILO

References

1. BarkerDJ.Fetal origins of coronary heart disease. BMJ 1995;311(6998):171–4.
2. SattarN, GreerIA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?BMJ 2002;325(7356):157–60.
3. GiffordR, AugustPA, CunninghamG, et al. The National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Bethesda, National Institutes of Health and National Heart, Lung and Blood Institute, 2000.
4. ChesleySC, AnnittoJE, CosgroveRA. The remote prognosis of eclamptic women. Sixth periodic report. Am J Obstet Gynecol 1976;124(5):446–59.
5. SibaiBM, el-NazerA, Gonzalez-RuizA. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986;155(5):1011–16.
6. IrgensHU, ReisaeterL, IrgensLM, LieRT.Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001;323(7323):1213–17.
7. SmithGC, PellJP, WalshD. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001;357(9273):2002–6.
8. FunaiEF, FriedlanderY, PaltielO, et al. Long-term mortality after preeclampsia. Epidemiology 2005;16(2):206–15.
9. VikseBE, IrgensLM, LeivestadT, SkjaervenR, IversenBM.Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008;359(8):800–9.
10. LykkeJA, Langhoff-RoosJ, SibaiBM, et al. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009;53(6):944–51.
11. BellamyL, CasasJP, HingoraniAD, WilliamsDJ.Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335(7627):974.
12. DuckittK, HarringtonD. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005;330(7491):565.
13. FunaiEF, PaltielOB, MalaspinaD, et al. Risk factors for pre-eclampsia in nulliparous and parous women: the Jerusalem perinatal study. Paediatr Perinat Epidemiol 2005;19(1):59–68.
14. SibaiBM, LindheimerM, HauthJ, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;339(10):667–71.
15. NessRB, MarkovicN, BassD, HargerG, RobertsJM.Family history of hypertension, heart disease, and stroke among women who develop hypertension in pregnancy. Obstet Gynecol 2003;102(6):1366–71.
16. QiuC, WilliamsMA, LeisenringWM, et al. Family history of hypertension and type 2 diabetes in relation to preeclampsia risk. Hypertension 2003;41(3):408–13.
17. KupfermincMJ, EldorA, SteinmanN,et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340(1):9–13.
18. RosendaalFR, SiscovickDS, SchwartzSM, et al. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 1997;90(5):1747–50.
19. RodieVA, FreemanDJ, SattarN, GreerIA.Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?Atherosclerosis 2004;175(2):189–202.
20. WalkerID. Prothrombotic genotypes and pre-eclampsia. Thromb Haemost 2002;87(5):777–8.
21. RosendaalFR, SiscovickDS, SchwartzSM, et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997;89(8):2817–21.
22. PowersRW, EvansRW, MajorsAK, et al. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 1998;179(6 Pt 1):1605–11.
23. FridstromM, NisellH, SjoblomP, HillensjoT.Are women with polycystic ovary syndrome at an increased risk of pregnancy-induced hypertension and/or preeclampsia?Hypertens Pregnancy 1999;18(1):73–80.
24. AcromiteMT, MantzorosCS, LeachRE, HurwitzJ, DoreyLG.Androgens in preeclampsia. Am J Obstet Gynecol 1999;180(1 Pt 1):60–3.
25. SattarN, ClarkP, HolmesA, et al. Antenatal waist circumference and hypertension risk. Obstet Gynecol 2001;97(2):268–71.
26. van den ElzenHJ, WladimiroffJW, Cohen-OverbeekTE, de BruinAJ, GrobbeeDE.Serum lipids in early pregnancy and risk of pre-eclampsia. Br J Obstet Gynaecol 1996;103(2):117–22.
27. HubelCA, RobertsJM, FerrellRE. Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene. Clin Genet 1999;56(4):289–96.
28. MagnussenEB, VattenLJ, Lund-NilsenTI, et al. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ 2007;335(7627):978.
29. WidmerM, VillarJ, BenigniA, et al. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet Gynecol 2007;109(1):168–80.
30. CockellAP, PostonL. Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension 1997;30(2 Pt 1):247–51.
31. SavvidouMD, HingoraniAD, TsikasD, et al. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 2003;361(9368):1511–17.
32. ChambersJC, FusiL, MalikIS, et al. Association of maternal endothelial dysfunction with preeclampsia. JAMA 2001;285(12):1607–12.
33. AgatisaPK, NessRB, RobertsJM, et al. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol 2004;286(4):H1389–93.
34. SpaandermanME, WillekesC, HoeksAP, EkhartTH, PeetersLL.The effect of pregnancy on the compliance of large arteries and veins in healthy parous control subjects and women with a history of preeclampsia. Am J Obstet Gynecol 2000;183(5):1278–86.
35. LampinenKH, RonnbackM, KaajaRJ, GroopPH.Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens 2006;24(4):751–6.
36. SeelyEW, SolomonCG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab 2003;88(6):2393–8.
37. SolomonCG, SeelyEW. Brief review: hypertension in pregnancy: a manifestation of the insulin resistance syndrome?Hypertension 2001;37(2):232–9.
38. ReavenGM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75(3):473–86.
39. WheatcroftSB, WilliamsIL, ShahAM, KearneyMT.Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 2003;20(4):255–68.
40. ButteNF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 2000;71(5 Suppl):1256S–61S.
41. KaajaR, TikkanenMJ, ViinikkaL, YlikorkalaO.Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995;85(3):353–6.
42. LaivuoriH, TikkanenMJ, YlikorkalaO. Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab 1996;81(8):2908–11.
43. WolfM, HubelCA, LamC, et al. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 2004;89(12):6239–43.
44. SmithGN, WalkerMC, LiuA, et al. A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 2009;200(1):58.e1–8.
45. KaajaRJ, GreerIA. Manifestations of chronic disease during pregnancy. JAMA 2005;294(21):2751–7.
46. WillersonJT, RidkerPM. Inflammation as a cardiovascular risk factor. Circulation 2004;109(21 Suppl 1):II2–10.
47. SjoholmA, NystromT. Endothelial inflammation in insulin resistance. Lancet 2005;365(9459):610–12.
48. RidkerPM, BuringJE, CookNR, RifaiN.C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107(3):391–7.
49. VickersM, FordI, MorrisonR, et al. Markers of endothelial activation and atherothrombosis in women with history of preeclampsia or gestational hypertension. Thromb Haemost 2003;90(6):1192–7.
50. HubelCA, PowersRW, SnaedalS, et al. C-reactive protein is elevated 30 years after eclamptic pregnancy. Hypertension 2008;51(6):1499–505.